Regulation & law · 21/02/2013
Meda Pharmaceuticals, Inc. Seeks Approval to Import Controlled Substances
Meda Pharmaceuticals, Inc. has submitted a notice of application to the U.S. government to import controlled substances, a move that requires regulatory approval from the Drug Enforcement Administration (DEA)
Original source language: Federal Register — Justice DepartmentOpen original release →